SCHEMBL4962167

SCHEMBL4962167

CCCN(C(=O)c1c(OS(C)(=O)=O)c(-c2cccc(F)c2)nc2ccccc12)c1cccc(F)c1

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 19/20 0.53
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961950 0.97 TACR3 (0.54) TACR3CYP3A4
SCHEMBL4964873 0.97 TACR3 (0.51) TACR3
SCHEMBL4963089 0.88 TACR3 (0.50) TACR3CYP3A4
SCHEMBL4963861 0.81 TACR3 (0.47) TACR3CYP3A4
SCHEMBL4962074 0.80 TACR3 (0.48) TACR3CYP3A4
SCHEMBL4961924 0.79 TACR3 (0.46) TACR3CYP3A4
SCHEMBL4963763 0.79 TACR3 (0.45) TACR3CYP3A4
SCHEMBL4667482 0.78 TACR3 (0.47) TACR3MAPTTHRB
SCHEMBL4967704 0.77 TACR3 (0.74) TACR3
SCHEMBL4966074 0.77 TACR3 (0.74) TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896418-A1 QUINOLINE 3 -SULFONATE ESTERS AS NK3 RECEPTOR MODULATORS AstraZeneca AB (SE) 2008-03-12 EP claimed
WO-2006137789-A1 Quinoline 3 -sulfonate esters as NK3 receptor modulators ASTRAZENECA AB (SE) 2006-12-28 WO claimed
EP-1896418-A1 QUINOLINE 3 -SULFONATE ESTERS AS NK3 RECEPTOR MODULATORS AstraZeneca AB (SE) 2008-03-12 EP disclosed
WO-2006137789-A1 Quinoline 3 -sulfonate esters as NK3 receptor modulators ASTRAZENECA AB (SE) 2006-12-28 WO disclosed